Gossamer Bio
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $9,480 | $95,842 | $0 | $6,784 |
Gross Profit | 9,480 | 94,850 | -986 | 5,778 |
EBITDA | -28,103 | 53,079 | -37,813 | -43,903 |
EBIT | -29,201 | 52,087 | -38,799 | -44,909 |
Net Income | -30,803 | 49,232 | -41,928 | -48,148 |
Net Change In Cash | 9,480 | 95,842 | 0 | 6,784 |
Free Cash Flow | 84,315 | 116,348 | -52,302 | -33,364 |
Cash | 28,464 | 86,877 | 38,863 | 32,109 |
Basic Shares | 226,346 | 238,543 | 225,735 | 225,409 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -4,385 | -4,429 | -5,167 | -4,268 |
EBITDA | -172,152 | -211,069 | -209,322 | -233,962 |
EBIT | -176,537 | -215,498 | -214,489 | -238,230 |
Net Income | -179,817 | -240,228 | -249,076 | -251,584 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -70,977 | -302,988 | 351,522 | |
Free Cash Flow | -159,158 | -187,507 | -190,511 | -201,243 |
Cash | 32,109 | 111,973 | 183,403 | 486,055 |
Basic Shares | 152,621 | 84,574 | 74,843 | 68,510 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.14 |
2024-06-30 | $0.22 |
2024-03-31 | -$0.19 |
2023-12-31 | -$0.21 |
